Healthcare -
Biotechnology - NASDAQ - US
$ 5.41
-8.99 %
$ 427 M
Market Cap
-2.77
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
MeiraGTx Holdings plc
| Revenue | 33.3 M |
| Cost Of Revenue | 23.8 M |
| Gross Profit | 9.49 M |
| Operating Expenses | 174 M |
| Operating Income | -164 M |
| Other Expenses | -16.4 M |
| Net Income | -148 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Revenue | 33.3 | 14.0 | 15.9 | 37.7 | 15.6 | 13.3 | 0 | 0 | 0 |
| GROSS PROFIT | |||||||||
| Cost Of Revenue | 23.8 | 0 | 8.7 | 7.9 | 0 | 0 | 2.1 | 0.7 | 0.2 |
| Gross Profit | 9.5 | 14.0 | 7.2 | 29.8 | 15.6 | 13.3 | (2.1) | (0.7) | (0.2) |
| OPERATING INCOME | |||||||||
| Operating Expenses | 173.7 | 151.1 | 132.3 | 110.9 | 78.1 | 71.6 | 78.1 | 31.7 | 20.1 |
| Selling, General and Administrative Expenses | 54.2 | 47.3 | 46.5 | 43.8 | 44.2 | 46.7 | 44.5 | 9.3 | 6.0 |
| Research and Development Expenses | 119.5 | 103.8 | 85.7 | 67.1 | 33.9 | 24.9 | 33.6 | 22.4 | 14.0 |
| Operating Income | (164.2) | (137.1) | (116.4) | (73.2) | (62.6) | (58.3) | (78.1) | (31.7) | (20.1) |
| PRE-TAX INCOME | |||||||||
| Interest Income Expense | 13.3 | 13.2 | 4.9 | 0.3 | 0.1 | 48.6 K | 33.4 K | 42.9 K | 25.4 K |
| Total Other Income | 16.4 | 53.0 | (13.3) | (6.4) | 4.6 | 3.5 | (5.2) | 0.6 | 0.3 |
| Pre-Tax Income | (147.8) | (84.0) | (129.6) | (79.6) | (58.0) | (54.7) | (83.3) | (31.0) | (19.8) |
| NET INCOME | |||||||||
| Tax Provision | 0 | 0 | 13.3 | (7.6) | (4.0) | (2.2) | (0.5) | (0.5) | (0.3) |
| Net Income | (147.8) | (84.0) | (142.9) | (72.0) | (54.0) | (52.6) | (82.9) | (31.0) | (19.5) |
| EPS | 2.12 | 1.49 | 3.16 | 1.63 | 1.43 | 1.58 | 4.37 | 3.62 | 1.01 |